109 related articles for article (PubMed ID: 20686371)
1. Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis.
Kim HS; Ju W; Jee BC; Kim YB; Park NH; Song YS; Kim SC; Kang SB; Kim JW
Int J Gynecol Cancer; 2010 May; 20(4):520-8. PubMed ID: 20686371
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of systematic retroperitoneal lymphadenectomy in patients with epithelial ovarian cancer: a Meta-analysis].
Gu HF; Zhou Y; Li YX; Ou YL; Liu JH
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3020-3025. PubMed ID: 27760666
[No Abstract] [Full Text] [Related]
3. The role systematic lymphadenectomy plays in determining the survival outcome for advanced ovarian cancer patients: a meta-analysis.
Xu D; Xue J; Rozan R; Li L
Ann Palliat Med; 2020 May; 9(3):912-920. PubMed ID: 32389005
[TBL] [Abstract][Full Text] [Related]
4. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis.
Chiyoda T; Sakurai M; Satoh T; Nagase S; Mikami M; Katabuchi H; Aoki D
J Gynecol Oncol; 2020 Sep; 31(5):e67. PubMed ID: 32808497
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients.
Iwase H; Takada T; Iitsuka C; Nomura H; Abe A; Taniguchi T; Takizawa K
J Gynecol Oncol; 2015 Oct; 26(4):303-10. PubMed ID: 26197771
[TBL] [Abstract][Full Text] [Related]
6. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.
Gao J; Yang X; Zhang Y
Jpn J Clin Oncol; 2015 Jan; 45(1):49-60. PubMed ID: 25387732
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
[TBL] [Abstract][Full Text] [Related]
8. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Systematic Lymphadenectomy in Patients With Optimally Debulked Advanced Ovarian Cancer: A Meta-Analysis.
Wang Y; Ren F; Song Z; Wang X; Zhang C; Ouyang L
Front Oncol; 2020; 10():86. PubMed ID: 32117740
[No Abstract] [Full Text] [Related]
10. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphadenectomy in node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Millan I; Iglesias E
Int J Gynecol Cancer; 2012 Jul; 22(6):987-92. PubMed ID: 22706223
[TBL] [Abstract][Full Text] [Related]
12. Advances in treatment of epithelial ovarian cancer.
Kikkawa F; Nawa A; Ino K; Shibata K; Kajiyama H; Nomura S
Nagoya J Med Sci; 2006 Jan; 68(1-2):19-26. PubMed ID: 16579172
[TBL] [Abstract][Full Text] [Related]
13. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
Timmermans M; Sonke GS; Van de Vijver KK; van der Aa MA; Kruitwagen RFPM
Eur J Cancer; 2018 Jan; 88():31-37. PubMed ID: 29179135
[TBL] [Abstract][Full Text] [Related]
14. The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials.
Lin Q; Liu W; Xu S; Li J; Tong J
J Ovarian Res; 2020 May; 13(1):56. PubMed ID: 32384898
[TBL] [Abstract][Full Text] [Related]
15. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.
Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M
Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials.
Purwar R; Ranjan R; Soni K; Pandey M; Upadhyay SK; Pai E; Kumar T
World J Surg Oncol; 2022 Nov; 20(1):367. PubMed ID: 36419077
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of initial surgical approach in stage I ovarian cancer.
Wu TI; Lee CL; Liao PJ; Huang KG; Chang TC; Chou HH; Wang CJ; Soong YK; Hsueh S; Lai CH
Chang Gung Med J; 2010; 33(5):558-67. PubMed ID: 20979707
[TBL] [Abstract][Full Text] [Related]
18. Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer.
Rutten MJ; Boldingh JH; Schuit E; Trum H; van Driel W; Mol BW; Kenter GG; Buist MR
Gynecol Oncol; 2014 Oct; 135(1):13-8. PubMed ID: 25093289
[TBL] [Abstract][Full Text] [Related]
19. Effect of retroperitoneal lymphadenectomy on prognosis of patients with epithelial ovarian cancer.
Wang Z; Xiong Z; Wang S
Chin Med J (Engl); 2003 Apr; 116(4):588-92. PubMed ID: 12875728
[TBL] [Abstract][Full Text] [Related]
20. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
